https://www.selleckchem.com/pr....oducts/hsp27-inhibit
This protocol has been registered at the Clinicaltrials.gov (NCT04539184). To our knowledge, this study is the first well-designed multi-centered randomized controlled trial to evaluate the effectiveness, safety, and cost-effectiveness of MSAT on acute neck pain. The results of this study will be useful for clinicians in primary medical institutions that frequently treat acute neck pain patients and for policymakers working with national health insurance. To our knowledge, this study is the first well-designed multi-centered
Like
Comment
Share
